⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001410709

Wallroth Donald E.

Reports to the SEC for 1 company · CAMBRIDGE, MA

Transactions

18

Companies

1

Filings

4

CIK

0001410709

Forms 4 and 5

Insider transactions

18 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2009-09-28	Molecular Insight Pharmaceuticals, Inc.M Exercise/Conversion	Former Chief Financial Officer	MExercise/Conversion	+13.5K sh	$3.93	+$53.1K	37,500
2009-09-28	Molecular Insight Pharmaceuticals, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Former Chief Financial Officer	MExercise/Conversion	−13.5K sh	—	—	0
2009-09-25	Molecular Insight Pharmaceuticals, Inc.M Exercise/Conversion	Former Chief Financial Officer	MExercise/Conversion	+4,000 sh	$3.93	+$15.7K	24,000
2009-09-25	Molecular Insight Pharmaceuticals, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Former Chief Financial Officer	MExercise/Conversion	−4,000 sh	—	—	0
2009-09-24	Molecular Insight Pharmaceuticals, Inc.M Exercise/Conversion	Former Chief Financial Officer	MExercise/Conversion	+4,000 sh	$3.93	+$15.7K	20,000
2009-09-24	Molecular Insight Pharmaceuticals, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Former Chief Financial Officer	MExercise/Conversion	−4,000 sh	—	—	0
2009-09-23	Molecular Insight Pharmaceuticals, Inc.M Exercise/Conversion	Former Chief Financial Officer	MExercise/Conversion	+4,000 sh	$3.93	+$15.7K	16,000
2009-09-23	Molecular Insight Pharmaceuticals, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Former Chief Financial Officer	MExercise/Conversion	−4,000 sh	—	—	0
2009-09-22	Molecular Insight Pharmaceuticals, Inc.M Exercise/Conversion	Former Chief Financial Officer	MExercise/Conversion	+4,000 sh	$3.93	+$15.7K	12,000
2009-09-22	Molecular Insight Pharmaceuticals, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Former Chief Financial Officer	MExercise/Conversion	−4,000 sh	—	—	0
2009-09-18	Molecular Insight Pharmaceuticals, Inc.M Exercise/Conversion	Former Chief Financial Officer	MExercise/Conversion	+8,000 sh	$3.93	+$31.4K	8,000
2009-09-18	Molecular Insight Pharmaceuticals, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Former Chief Financial Officer	MExercise/Conversion	−8,000 sh	—	—	0
2009-08-22	Molecular Insight Pharmaceuticals, Inc.D Disposition to Issuer	Former Chief Financial Officer	DDisposition to Issuer	−13.5K sh	—	—	0
2009-05-22	Molecular Insight Pharmaceuticals, Inc.S Sale	Former Chief Financial Officer	SSale	−4,000 sh	$3.80	−$15.2K	16,000
2009-05-22	Molecular Insight Pharmaceuticals, Inc.S Sale	Former Chief Financial Officer	SSale	−2,500 sh	$3.75	−$9,375.5	13,500
2009-05-12	Molecular Insight Pharmaceuticals, Inc.Employee Stock Option (right to buy)A Award	Former Chief Financial Officer	AAward	+30K sh	—	—	30,000
2009-05-12	Molecular Insight Pharmaceuticals, Inc.Employee Stock Option (right to buy)A Award	Former Chief Financial Officer	AAward	+60K sh	—	—	60,000
2009-05-12	Molecular Insight Pharmaceuticals, Inc.Employee Stock Option (right to buy)A Award	Former Chief Financial Officer	AAward	+90K sh	—	—	90,000

Recent filings

4

Accepted (ET)
Feb 165
Wallroth Donald E.0001181431-10-009455
SEC(opens sec.gov)
May 264
Wallroth Donald E.0001209191-09-028868
SEC(opens sec.gov)
May 144
Wallroth Donald E.0001209191-09-026570
SEC(opens sec.gov)
May 144/A
Wallroth Donald E.0001209191-09-026746
SEC(opens sec.gov)

Companies

1

Molecular Insight Pharmaceuticals, Inc.Former Chief Financial Officer

Address

MOLECULAR INSIGHT PHARMACEUTICALS 160 SECOND STREET

CAMBRIDGE, MA, 02142